> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Amphastar ANDA Approved for Generic Lovenox Vials
- URL: https://www.fdaweb.com/amphastar-anda-approved-for-generic-lovenox-vials/
- Published: 2019-03-20T12:00:00.000Z
- Updated: 2026-09-15T01:14:10.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5143654

FDA has approved an Amphastar Pharmaceuticals ANDA for blood thinner enoxaparin sodium injection 300mg/3mL (100mg/mL) multiple dose vials, a generic copy of Sanofi-Aventis’ Lovenox. Amphastar also manufactures and distributes enoxaparin sodium injection in prefilled syringes. Enoxaparin sodium is used to treat and prevent deep vein thrombosis and pulmonary embolism including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome and heart attacks. Annual sales are estimated to be $11 million, according to the company.